Novo Nordisk has said it believes the allegations in the lawsuits are 'without merit' and the company will 'vigorously defend against these claims.' And Eli Lilly said 'patient safety is Lilly's top priority' and also added that it will 'vigorously defend against these claims'
However, Rybelsus and the Ozempic pill can still be prescribed off-label for weight loss, which is why theyre included for comparison in the following dosing chart
Alternatively, some patients may prefer dose reduction strategies
Managing Side Effects During the Switch Nausea and appetite suppression tend to be more pronounced with tirzepatide initially, especially in the first 1-2 weeks after starting
Always confirm timing with your prescribing provider, as individual medications have specific requirements
Importantly, the study adds real-world evidence to the growing body of clinical trial data showing that glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and dual agonists may modify the course of liver disease, not just metabolic risk